# Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)

> **NCT06511349** · EARLY_PHASE1 · RECRUITING · sponsor: **RenJi Hospital** · enrollment: 21 (estimated)

## Conditions studied

- Type 1 Primary Hyperoxaluria

## Interventions

- **DRUG:** YOLT-203

## Key facts

- **NCT ID:** NCT06511349
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-15
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2025-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06511349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06511349, "Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06511349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*